Feedback
Settings

Settings

Goto Application

1. WO2021229591 - NOVEL USE OF NON-IONIC SURFACTANT FOR THE TREATMENT OF COVID–19

PermaLink
Publication Number WO/2021/229591
Publication Date 18.11.2021
International Application No. PCT/IN2020/050643
International Filing Date 25.07.2020
IPC
A61K 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61K 39/215 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
215Coronaviridae, e.g. avian infectious bronchitis virus
C07K 14/165 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
165Coronaviridae, e.g. avian infectious bronchitis virus
CPC
A61K 31/765
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
74Synthetic polymeric materials
765Polymers containing oxygen
A61K 36/47
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
A61P 31/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
C12N 2770/20022
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2770ssRNA Viruses positive-sense
00011ssRNA Viruses positive-sense
20011Coronaviridae
20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applicants
  • KRISHNAMACHARI, Ramu [IN]/[IN]
Inventors
  • RITHVIK, K
Priority Data
20204101978511.05.2020IN
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) NOVEL USE OF NON-IONIC SURFACTANT FOR THE TREATMENT OF COVID–19
(FR) NOUVELLE UTILISATION D'UN TENSIOACTIF NON IONIQUE POUR LE TRAITEMENT DE LA COVID–19
Abstract
(EN) The present invention relates to a novel use of non-ionic surfactants for the treatment of diseases caused by viruses. The present invention particularly relates to the use of non-ionic surfactants for the treatment of a disease known as COVID 19 caused by coronavirus SARS-CoV-2. The present invention further teaches the use of taste masking agents/excipients. The present invention is further believed to be related to cleansing the coronaviruses from buccal cavities, throat or within the body of a subject by not allowing the said virus to attach to any cells of mucosal layers or epithelial cells thus allowing them to pass out of the body or getting digested inside the body. For this reason the molecules or the composition used herein of the present invention is termed by the applicant as "INTERNAL SOAP".
(FR) La présente invention se rapporte à une nouvelle utilisation de tensioactifs non ioniques pour le traitement de maladies provoquées par des virus. La présente invention se rapporte en particulier à l'utilisation de tensioactifs non ioniques pour le traitement d'une maladie connue sous le nom de COVID 19, provoquée par le coronavirus SARS-CoV-2. La présente invention enseigne en outre l'utilisation d'agents/excipients de masquage du goût. La présente invention est en outre censée être liée au nettoyage des coronavirus des cavités buccales, de la gorge ou de l'intérieur du corps d'un sujet en ne permettant pas audit virus de se fixer à des cellules de couches muqueuses ou à des cellules épithéliales, ce qui lui permet de sortir du corps ou d'être digéré à l'intérieur du corps. Pour cette raison, les molécules ou la composition utilisées dans la présente invention sont désignées par le demandeur par l'expression " SAVON INTERNE ".
Latest bibliographic data on file with the International Bureau
# -